Abstract
CDCP1, a novel stem cell marker, is expressed in hematopoietic cell line K562 but not in Jurkat. When CDCP1 promoter was transfected exogenously, Jurkat showed comparable promoter activity with K562, suggesting that the factor to enhance transcription was present but interfered to function in Jurkat. The reporter assay and si-RNA-mediated knockdown experiment revealed that zfp67, a zinc-finger protein, enhanced CDCP1 transcription. Amount of zfp67 in Jurkat was comparable with K562, but chromatin immunoprecipitation showed that zfp67 bound to CDCP1 promoter in K562 but not in Jurkat. There are CpG sequences around the promoter of CDCP1, which were heavily methylated in Jurkat but not in K562. Addition of demethylating reagent to Jurkat induced CDCP1 expression, and increased the zfp67 binding to CDCP1 promoter. Among normal hematopoietic cells such as CD34+CD38− cells, lymphocytes and granulocytes, inverse correlation between proportion of methylated CpG sequences and CDCP1 expression level was found. Demethylation of CpG sequences in lymphocytes, in which CpG sequences were heavily methylated, induced CDCP1 expression and its expression level further increased through zfp67 overexpression. The methylation of DNA appeared to regulate the cell-type-specific expression of CDCP1 through the control of interaction between chromatin DNA and transcription factors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Scherl-Mostageer M, Sommergruber W, Abseher R, Hauptmann R, Ambros P, Schweifer N . Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene 2001; 20: 4402–4408.
Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D et al. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Oncogene 2003; 22: 1783–1794.
Conze T, Lammers R, Kuci S, Scherl Mostageer M, Schweifer N, Kanz L et al. CDCP1 is a novel marker for hematopoietic stem cells. Ann NY Acad Sci 2003; 996: 222–226.
Buhring H-J, Kuci S, Conze T, Rathke G, Bartolovic K, Grunebach F et al. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin. Stem Cells 2004; 22: 334–343.
Brown TA, Yang TM, Zaitsevskaia T, Xia Y, Dunn CA, Sigle RO et al. Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia. J Biol Chem 2004; 279: 14772–14783.
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821–5828.
Morii E, Oboki K . MITF is necessary for generation of prostaglandin D2 in mouse mast cells. J Biol Chem 2004; 279: 48923–48929.
Galera P, Musso M, Ducy P, Karsenty G . c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc Natl Acad Sci USA 1994; 91: 9372–9376.
He X, He X, Dave VP, Zhang Y, Hua X, Nicolas E et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 2005; 433: 826–833.
Feinberg AP, Tycko B . The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143–153.
Benz Jr EJ, Murnane MJ, Tonkonow BL, Berman BW, Mazur EM, Cavallesco C et al. Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci USA 1980; 77: 3509–3513.
Tetteroo PA, Massaro F, Mulder A, Schreuder-van Gelder R, von dem Borne AE . Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leukemia Res 1984; 8: 197–206.
Deb-Rinker P, Ly D, Jezierski A, Sikorska M, Walker PR . Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J Biol Chem 2005; 280: 6257–6260.
Acknowledgements
We thank Mr M Kohara, Ms M Sugano and Ms T Sawamura (Osaka University) for technical supports. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, and from the Osaka Cancer Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kimura, H., Morii, E., Ikeda, Ji. et al. Role of DNA methylation for expression of novel stem cell marker CDCP1 in hematopoietic cells. Leukemia 20, 1551–1556 (2006). https://doi.org/10.1038/sj.leu.2404312
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404312
Keywords
This article is cited by
-
Identification of CD318 (CDCP1) as novel prognostic marker in AML
Annals of Hematology (2020)
-
Regulation of inside-out β1-integrin activation by CDCP1
Oncogene (2018)